Quantum BioPharma Ltd (NASDAQ:QNTM) has a beta value of 0.50 and has seen 1.03 million shares traded in the last trading session. The company, currently valued at $62.36M, closed the last trade at $23.01 per share which meant it lost -$11.99 on the day or -34.26%% during that session. The QNTM stock price is -66.23% off its 52-week high price of $38.25 and 88.27% above the 52-week low of $2.70.
Quantum BioPharma Ltd (NASDAQ:QNTM) trade information
Sporting -34.26%% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the QNTM stock price touched $23.01 or saw a rise of 39.84%. Year-to-date, Quantum BioPharma Ltd shares have moved 78.79%, while the 5-day performance has seen it change 16.86%. Over the past 30 days, the shares of Quantum BioPharma Ltd (NASDAQ:QNTM) have changed 87.07%.
Quantum BioPharma Ltd (QNTM) estimates and forecasts
The company’s shares have gained 443.97% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 48.95% over the past 5 years.
QNTM Dividends
Quantum BioPharma Ltd is expected to release its next earnings report on 2025-May-14 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Quantum BioPharma Ltd (NASDAQ:QNTM)’s Major holders
Insiders own 11.41% of the company shares, while shares held by institutions stand at 19.90% with a share float percentage of 22.46%. Investors are also buoyed by the number of investors in a company, with Quantum BioPharma Ltd having a total of 17.0 institutions that hold shares in the company.
